Medical cannabis operators that file by June 26 can preserve expedited DEA review and pending-application protections. The immediate work is not rebuilding every compliance program from scratch, but confirming that licenses, records, ownership disclosures, security controls, SOPs, and product flows can withstand closer federal scrutiny.
Sara’s key insights for medical cannabis operators are:
- Deadline: File by June 26 to preserve expedited DEA review and pending-application protections.
- Who is affected: State-licensed medical cannabis cultivators, manufacturers, distributors, and dispensers.
- What to confirm now: State licenses, ownership information, security and inventory controls, SOPs, and traceability records should be current, consistent, and easy to retrieve.
- Strategic point: Treat registration as an operational-readiness exercise, not merely a filing deadline.
